Phase II study of IRInotecan treatment after COmbined chemo‐immunotherapy for extensive‐stage small cell lung cancer: Protocol of IRICO study.

Autor: Tomono, Hiromi1,2 (AUTHOR), Taniguchi, Hirokazu1,3 (AUTHOR) hirokazu_pc@nagasaki-u.ac.jp, Fukuda, Minoru3,4 (AUTHOR), Ikeda, Takaya2 (AUTHOR), Nagashima, Seiji2 (AUTHOR), Akagi, Kazumasa1 (AUTHOR), Ono, Sawana1 (AUTHOR), Umeyama, Yasuhiro1 (AUTHOR), Shimada, Midori1,5 (AUTHOR), Gyotoku, Hiroshi1 (AUTHOR), Takemoto, Shinnosuke1 (AUTHOR), Hisamatsu, Yasushi6 (AUTHOR), Morinaga, Ryotaro6 (AUTHOR), Tagawa, Ryuta7 (AUTHOR), Ogata, Ryosuke1,7 (AUTHOR), Dotsu, Yosuke7 (AUTHOR), Senju, Hiroaki7,8 (AUTHOR), Soda, Hiroshi7 (AUTHOR), Nakatomi, Katsumi9 (AUTHOR), Hayashi, Fumiko4 (AUTHOR)
Zdroj: Thoracic Cancer. Oct2023, Vol. 14 Issue 28, p2890-2894. 5p.
Databáze: Academic Search Ultimate
Externí odkaz:
Nepřihlášeným uživatelům se plný text nezobrazuje